In 2011, a group of entrepreneurs invested in a philanthropic effort to treat cancer via this discovery. Together with the inventor of the original ISCOM technology, the group created a business structure, bringing in additional expertise and founded several companies focused to exploiting the patent portfolio in cancer therapy.
THE MANAGEMENT TEAM
|Johan Monie||Managing Director, Board Memberemail@example.com|
|Lars Monie||Board Memberfirstname.lastname@example.org|
|Niclas Högberg||Board Memberemail@example.com|